Melatonin attenuates smoking-induced atherosclerosis by activating the Nrf2 pathway via NLRP3 inflammasomes in endothelial cells

Abstract

Substantial evidence suggests that the effects of smoking in atherosclerosis are associated with inflammation mediated by endothelial cells. However, the mechanisms and potential drug therapies for smoking-induced atherosclerosis remain to be clarified. Considering that melatonin exerts beneficial effects in cardiovascular diseases, we examined its effects on cigarette smoke-induced vascular injury. We found that cigarette smoke extract (CSE) treatment induced NLRP3-related pyroptosis in human aortic endothelial cells (HAECs). CSE also induced ROS generation and upregulated the Nrf2 pathway in HAECs. Furthermore, pretreatment of HAECs with Nrf2-specific siRNA and an Nrf2 activator revealed that Nrf2 can inhibit CSE-induced ROS/NLRP3 activation. Nrf2 also improved cell viability and the expression of VEGF and eNOS in CSE-treated HAECs. In balloon-induced carotid artery injury model rats exposed to cigarette smoke, melatonin treatment reduced intimal hyperplasia in the carotid artery. Mechanistic studies revealed that compared with the control group, Nrf2 activation was increased in the melatonin group, whereas ROS levels and the NLRP3 inflammasome pathway were inhibited. These results reveal that melatonin might effectively protect against smoking-induced vascular injury and atherosclerosis through the Nrf2/ROS/NLRP3 signaling pathway. Overall, these observations provide compelling evidence for the clinical use of melatonin to reduce smoking-related inflammatory vascular injury and atherosclerosis.

LKB1 Regulates Vascular Macrophage Functions in Atherosclerosis

“…The etiology of atherosclerosis is more complex than previously thought, and its risk factors include hypertension, hyperlipidemia, heavy smoking, diabetes, and genetic predisposition ( Lien et al, 2020 ; Wang and Ge, 2021 ; Zhao et al, 2021 ). Generally, different factors interact and converge to affect the formation of foam cells and the maintenance of vascular inflammation, thereby promoting the occurrence of atherosclerosis ( Poznyak et al, 2020a ).…”

A Potential Target for Diabetic Vascular Damage: High Glucose-Induced Monocyte Extracellular Vesicles Impair Endothelial Cells by Delivering miR-142-5p

“…We and others previously found that by inhibiting NLRP3 signaling via Nrf2 signaling activation, endothelial cells were protected against stress from cigarette smoke extract ( Hu et al, 2018 ; Zhao Z. et al, 2021 ; Jin et al, 2021 ). A series of studies found that stressors, including smoking and high glucose, stimulated inflammation in vascular cells via Nrf2 downregulation ( Miao et al, 2013 ; Wang et al, 2021 ).…”

NLRP3-Mediated Inflammation in Atherosclerosis and Associated Therapeutics

“…The decreased AS plaque size and vulnerability were determined in atherosclerotic mouse model treated with melatonin. Reduced activation of NLRP3 inflammasome and maturation of IL-1 β were also found in atherosclerotic lesions ( Zhao Z. et al, 2021 ). Ma et al showed that melatonin partially prevented atherosclerotic progression through inducing mitophagy and attenuating Sirt3/FOXO3a/Parkin-mediated NLRP3 inflammasome activation ( Ma et al, 2018 ).…”